Work

Worse Survival and Gastrointestinal Toxicity Outcomes Among Patients Receiving Proton Pump Inhibitors During Checkpoint Inhibitor Therapy

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of the National Comprehensive Cancer Network

DOI: 10.6004/jnccn.2025.7023

Authors: Malek Shatila, Samanthika Devalaraju, Kei Takigawa, Christine Catinis, Irene Lee, Elliot Baerman, Sean Ngo, Nitish Mittal, Stephen Glombicki, Antonio Pizuorno Machado, Linfeng Lu, Abdullah Sagar Aleem, John Thompson, Pauline Funchain, Shilpa Grover, Hao Chi Zhang, Anusha Shirwaiker Thomas, Yinghong Wang

Institutions: The University of Texas MD Anderson Cancer Center, Baylor College of Medicine, The University of Texas Health Science Center at Houston, Fred Hutch Cancer Center, Stanford Cancer Institute, Brigham and Women's Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411410433

FWCI: 2.519

Cites: 52

Cited by: 7

Related to: 10